Category : Featured

3 Marijuana Stocks That Are Breaking the Mold

Marijuana isn’t just another growth industry. It has the potential to be a once-in-a-generation growth opportunity for patient investors who have a keen eye for this fast-paced industry. Between 2018 and 2030, various Wall Street firms have called for a…

Read more →

The post 3 Marijuana Stocks That Are Breaking the Mold appeared first on Growth Stock Network.

CONTINUE READING

2 Top Cannabis Stocks to Consider Buying Now

Last year, cannabis stocks entered the mainstream, thanks to the legalization of recreational marijuana in Canada and the increasing momentum of the legalization movement in the United States. Investor interest in this space remains in high gear, driven by strong performances…

Read more →

The post 2 Top Cannabis Stocks to Consider Buying Now appeared first on Growth Stock Network.

CONTINUE READING

Better Buy: Canopy Growth vs. Scotts Miracle-Gro

If you’re considering buying either Canopy Growth (NYSE:CGC) or Scotts Miracle-Gro (NYSE:SMG), you probably wish you could turn back the hands of time. Both stocks are up more than 50% so far in 2019. The nice gain is a welcome change for Scotts, but just…

Read more →

The post Better Buy: Canopy Growth vs. Scotts Miracle-Gro appeared first on Growth Stock Network.

CONTINUE READING

Tilray Resolves a Small Issue but Bigger Problems Remain

Chances are that investors would struggle to find a bigger (or buzzier) long-term growth opportunity at the moment than marijuana. Although black market cannabis sales continue to dominate, legal channel sales are soaring as new countries and U.S. states wave…

Read more →

The post Tilray Resolves a Small Issue but Bigger Problems Remain appeared first on Growth Stock Network.

CONTINUE READING

Why are shares of Hexo Corp. trading down 6% today?

It’s been a great year for HEXO Corp. (NYSEMKT:HEXO) so far. The company reported tremendous revenue growth in its first full quarter of sales in the Canadian adult-use recreational marijuana market. It announced the acquisition of Newstrike Brands. And HEXO even received some love from…

Read more →

The post Why are shares of Hexo Corp. trading down 6% today? appeared first on Growth Stock Network.

CONTINUE READING

10 Numbers to Focus On When Canopy Growth Reports Its Fourth-Quarter Results

Sure, earnings season may have passed for the lion’s share of brand-name companies, but that doesn’t mean earnings reports cease altogether. Next week, the biggest name in all of cannabis, Canopy Growth (NYSE:CGC), will be dishing on its performance in the fourth…

Read more →

The post 10 Numbers to Focus On When Canopy Growth Reports Its Fourth-Quarter Results appeared first on Growth Stock Network.

CONTINUE READING

Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today

What happened Shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) were shooting 18.9% higher as of 10:57 a.m. EDT on Tuesday. The big jump came after the biotech announced that it received a new patent for treating autism spectrum disorders using synthetic cannabidiol (CBD). So what…

Read more →

The post Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today appeared first on Growth Stock Network.

CONTINUE READING

Why is Marijuana Stock Tilray Soaring 20% Today?

Tilray shares surged more than 13% Monday in premarket trade after the Canadian pot company announced it struck a deal with its majority shareholder, a cannabis company backed by venture capitalist Peter Thiel, to sell the fund’s stake gradually over the…

Read more →

The post Why is Marijuana Stock Tilray Soaring 20% Today? appeared first on Growth Stock Network.

CONTINUE READING

Why Marijuana’s Top Dividend Stock Has High Hopes for Future Growth

Marijuana stocks vaulted into the limelight in 2018, and their performance in 2019 has generally been extremely strong. As more states have embraced cannabis by legalizing it for medical or recreational purposes, the opportunities for cannabis producers to capitalize on strong…

Read more →

The post Why Marijuana’s Top Dividend Stock Has High Hopes for Future Growth appeared first on Growth Stock Network.

CONTINUE READING

Analyst Likes Tilray In The Long Run, But Says Stock Is Overvalued Right Now

Cronos Group Inc (NASDAQ: CRON) and several other cannabis stocks have received some love from Wall Street analysts in the past week, but one analyst said Wednesday the 2019 struggles for Tilray Inc (NASDAQ: TLRY) will continue in the near term. The Analyst Oppenheimer analyst Rupesh…

Read more →

The post Analyst Likes Tilray In The Long Run, But Says Stock Is Overvalued Right Now appeared first on Growth Stock Network.

CONTINUE READING
1 2 3 50